Electrode margins expected to widen; US tariffs loom on result day
Graphite India enters Q2 FY27 on the back of strong Q1 momentum (₹171 Cr PAT, +29% YoY). Analyst consensus is bullish (Strong Buy, target ₹923–948), banking on margin expansion as global electrode pricing firms. The Street watches for execution on margin guidance amid US antidumping duty headwinds.
The Setup
Graphite India enters Q2 FY27 riding strong momentum from Q1, when consolidated revenue surged 26.3% YoY to ₹842 Cr and PAT jumped 29% to ₹171 Cr. The margin story is the headline: EBITDA margin already expanded to 17.1% in Q1, and the Street's consensus bet is on further widening in Q2 as global graphite electrode prices firm. Electric arc furnace (EAF) steelmaking remains the demand driver; with India's crude steel output up 9.7% YoY in Q4 FY26, domestic demand is robust. The question on result day: does the company sustain or exceed that margin momentum?
What to Expect
~₹870–920 Cr
Q1 baseline ₹842 Cr on steady electrode demand; margin expansion, not volume swing, drives upside
~₹185–210 Cr
On-plan progression from Q1 ₹171 Cr if margin momentum holds; sensitive to FX, one-offs
~17–19%
Guidance anchored to global electrode price realizations; Q1 was 17.1%; expect widening if pricing holds
Watch for seasonality
Q2 typically sees higher receivables; monitor DSO and free cash generation
A strong print: Revenue in the ₹890–920 Cr range with EBITDA margin ≥18% and consolidated PAT ≥₹195 Cr. This would signal pricing power intact and cost control holding. Commentary confirming no material margin pressure from trade duties ahead would be reassuring. A weak print: Revenue missing ₹870 Cr, or EBITDA margin sliding below 16.5%. This could signal demand softness or input-cost pressure, and would raise questions about full-year guidance. Any downward revision to FY27 margin outlook on tariff uncertainty would alarm the Street.
On Track?
Graphite India had a strong FY26 and Q1 FY27 validates the upswing. Management has not published explicit full-year guidance, but the trajectory suggests confidence: Q1 already delivered 29% PAT growth YoY, and the Street's consensus price target of ₹923–948 (25–28% upside from current ₹735) implies consensus earnings power through H2 FY27. The company's ₹58.71 Cr investment in associate Godi India (announced October 23) flags capital deployment appetite and confidence in the cycle. The margin expansion thesis is the load-bearing assumption—if Q2 confirms it, the stock should hold Street support.
What the Street Says
Since Last Quarter
1 · US Tariff Preliminaries (Sep 29, 2026)
US Department of Commerce issued preliminary antidumping duty of 12.22% and countervailing duty of 3.68% on large-diameter graphite electrodes from India. Final determination expected December 2026. Impact: export margins to US may compress if duties are maintained; however, Indian steelmakers' strong demand may offset lost US volume. Watch for management's commentary on export mix and pricing strategy on result day.
2 · Godi India Investment (Oct 23, 2026)
Graphite India subscribed ₹58.71 Cr to rights issue in associate Godi India Private Limited, acquiring 7,78,575 shares. Signals confidence in capital deployment and Godi's growth trajectory. Minor positive for optionality; doesn't affect Q2 reported earnings but flags management's strategic M&A appetite.
3 · German Operations Closure (Jul 8, 2026)
Graphite India announced discontinuation of Graphite Specialities and Coating divisions in Germany, citing lasting Russia-Ukraine war impact and weak demand. One-off charges may appear in FY27 results; offset by lower opex. Immaterial to Q2 but clarifies geographic footprint risk going forward.
4 · ESG Score Revisions (Aug–Oct 2026)
Multiple ESG rating updates (NSE: 62, SES: 65.1, Niche99: 66, CRISIL: 60). Routine disclosure; no material operational impact. Reflects company's focus on governance and sustainability—positive signal for long-term institutional flows.
5 · GST Demand Clarification (Jul 24, 2026)
Company clarified a prior GST Department order. The Additional Commissioner (Appeals) partially allowed the company's appeal, modifying the original demand. Routine tax matter; no material impact on Q2 P&L.
The Watch List
1 · Margin Hold: EBITDA margin ≥17% signals pricing power intact
Investors will scrutinize Q2 EBITDA margin vs Q1's 17.1%. If it holds or widens, the consensus narrative holds. If it slips below 16.5%, questions will surface on cost inflation, demand softness, or tariff overhang.
2 · Tariff visibility: management guidance on Dec ruling and price strategy
The Street wants to hear whether management expects to pass tariff costs to customers (domestic) or absorb them (exports). If commentary is cautious, expect a stock pullback post-result. If confident, likely a re-rate.
3 · Domestic vs export mix and volume trends
Q2 commentary should clarify whether the company is seeing sustained EAF demand in India, or if Q1's volume growth was a one-off. A strong domestic commentary would ease tariff anxiety.
4 · FY27 guidance revision (or lack thereof)
If management reiterates full-year margin/earnings guidance unchanged, that's a buy signal. Any downward revision on tariff or demand concerns would disappoint and likely trigger a 5–10% stock pullback.
Graphite India enters Q2 FY27 as a margin-expansion play on the back of firming global electrode prices and robust EAF steelmaking demand in India. The Street's Strong Buy consensus prices in a ₹923–948 target, but all that depends on the company holding Q2 EBITDA margin ≥17% and signaling confidence on US tariff headwinds ahead. The company's ₹58.71 Cr Godi investment flags management confidence; the German closure and ESG refresh are routine housekeeping.
On result day (November 3), three things matter: (1) Does the company deliver revenue in the ₹870–920 Cr range and PAT ≥₹185 Cr? (2) Does EBITDA margin hold or widen from Q1's 17.1%? (3) What does management say about US tariff strategy and FY27 guidance? A beat on margins + confident tariff messaging would likely drive a re-rate; a miss or cautious commentary would test support at ₹735.
Informational and educational content only. Not investment advice.